Surrozen, Inc./DE Accumulated Other Comprehensive Income
Surrozen, Inc./DE (SRZN) had Accumulated Other Comprehensive Income of $0 as of 2023-12-31, per its 10-K filed 2024-04-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-04-10
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$50.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-10 |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$50.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$241.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | -$424.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$476.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$429.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$119.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$16.00K 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |